| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/18/2007 | CN100998825A Oral Chinese medicine for treating yin blood insufficiency type virus myocarditis |
| 07/18/2007 | CN100998824A Oral Chinese medicine for treating virus myocarditis |
| 07/18/2007 | CN100998817A Orally taken Chinese medicine for treating constitutional hypotension |
| 07/18/2007 | CN100998798A Medicine for treating brain arteriosclerosis |
| 07/18/2007 | CN100998770A Hypertensor plaster with tranquilizing function |
| 07/18/2007 | CN100998765A Oral traditional Chinese medicine for treating hypotension of limbs-coldness type |
| 07/18/2007 | CN100998762A Oral traditional Chinese medicine for treating blood stasis type hypotension |
| 07/18/2007 | CN100998761A Oral traditional Chinese medicine for treating dizziness type hypotension |
| 07/18/2007 | CN100998760A Oral traditional Chinese medicine for treating parched mouth type hypotension |
| 07/18/2007 | CN100998759A Oral traditional Chinese medicine for treating hypotension |
| 07/18/2007 | CN100998756A Traditional Chinese medicine capsule for treating cardiac failure |
| 07/18/2007 | CN100998755A Oral traditional Chinese medicine for treating insomnic hypertension |
| 07/18/2007 | CN100998754A Oral traditional Chinese medicine for treating vertiginous type hypertension |
| 07/18/2007 | CN100998753A Oral traditional Chinese medicine for treating red-eye type hypertension |
| 07/18/2007 | CN100998750A Oral traditional Chinese medicine for treating viral myocarditis of yin deficiency and blood stasis type |
| 07/18/2007 | CN100998694A Oral traditional Chinese medicine for treating hypertension of deficiency of yin of liver and kidney type |
| 07/18/2007 | CN100998691A Oral traditional Chinese medicine for treating hypotension of qi deficiency type |
| 07/18/2007 | CN100998684A Oval traditional Chinese medicine for treating hypopiesi of heart-spleen deficiency type |
| 07/18/2007 | CN100998670A Application of Qingkailing for preparing medicine to treat or prevent ischemic cerebrovascular diseases |
| 07/18/2007 | CN100998669A Method for preparing brain-clearing powder medicine containing Chinese ilex |
| 07/18/2007 | CN100998651A Medicine for treating thromboembolia type disease and its preparing method |
| 07/18/2007 | CN100998649A Traditional Chinese medicine for treating cold-dampness type hypotension |
| 07/18/2007 | CN100998648A Method for preparing compound red-rooted salvia enteric tablet |
| 07/18/2007 | CN100998646A Method for processing Chinese herb medicine-red rooted salvia |
| 07/18/2007 | CN100998645A Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease, prepairng method and use thereof |
| 07/18/2007 | CN100998644A Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease, preparing method and use thereof |
| 07/18/2007 | CN100998643A Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease, and preparing method and use thereof |
| 07/18/2007 | CN100998642A Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease, preparing method and use thereof |
| 07/18/2007 | CN100998641A Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease, preparing method and use thereof |
| 07/18/2007 | CN100998628A Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease preparing method and use thereof |
| 07/18/2007 | CN100998627A Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular disease preparing method and use thereof |
| 07/18/2007 | CN100998626A Method for preparing extract of korea thistle leaf |
| 07/18/2007 | CN100998622A Traditional Chinese medicine preparations for treating cardiovascular and cerebrovascular diseases the preparation method and use thereof |
| 07/18/2007 | CN100998618A Method for continuously extracting sea-buckthorn oil and sea buckthorn flavonoid by using supercritical CO2 fluid |
| 07/18/2007 | CN100998617A Quality control method for Xindakang preparation |
| 07/18/2007 | CN100998616A Medicine for treating haemorrhoids and its preapring method |
| 07/18/2007 | CN100998600A Traditional Chinese medicine preparation for treating cardiovascular or cerebrovascular diseases, preparing method and use thereof |
| 07/18/2007 | CN100998592A Microemulsion containing matrine |
| 07/18/2007 | CN100998588A Precursor medicine of vegetative estrogen able to release nitrogen monooxide slowly and preparing method therefor |
| 07/18/2007 | CN100998584A Medicine composition used for injection and its preparing method |
| 07/18/2007 | CN100998573A Effect and use of capusle prepared by blending multiple sola-red-agent |
| 07/18/2007 | CN100998565A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998552A Composition of oral medicine preparation and its preparing method |
| 07/18/2007 | CN100998430A Method for making thin cake containing degreased peanut |
| 07/18/2007 | CN100998388A Nutrient porridge and its production method |
| 07/18/2007 | CN100998362A Chewing gum containing cranberry composition |
| 07/18/2007 | CN100998359A Health-care tea with function of preventing and treating hypertension |
| 07/18/2007 | CN100998313A Production method of ginseng culture root extraction with high content of ginsenoside and its use |
| 07/17/2007 | US7244849 Reaction of a phenoxypropionic acid compound with a trifluoromethylphenylthiazole compound; for manufacture of a medicament for treatment of a human peroxisome proliferator activated receptor alpha mediated disease or condition such as hypercholesteremia, cardiovascular disease |
| 07/17/2007 | US7244846 Substituted benzofuran-2-carboxamides derivatives |
| 07/17/2007 | US7244763 Compounds that modulate PPAR activity and methods of preparation |
| 07/17/2007 | US7244758 N-type calcium channel blockers |
| 07/17/2007 | US7244756 For increasing blood-brain barrier permeability |
| 07/17/2007 | US7244754 For therapy of Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244410 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/17/2007 | US7243859 Adjustable non-electric liquid air freshener device |
| 07/17/2007 | CA2395558C Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 07/17/2007 | CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion |
| 07/17/2007 | CA2321369C Dosing regimens for lasofoxifene |
| 07/17/2007 | CA2298445C Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 07/17/2007 | CA2285542C N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 07/17/2007 | CA2254528C Treatment of ischemia reperfusion injury and treatment of cellular dysfunction including arrhythmia and heart failure subsequent to myocardial infarction |
| 07/17/2007 | CA2132887C Tricyclic 1-aminoethylpyrrole-derivatives |
| 07/12/2007 | WO2007079406A1 Small molecule inhibitors of pdz interactions |
| 07/12/2007 | WO2007079186A2 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors |
| 07/12/2007 | WO2007078990A2 Modified lysine-mimetic compounds |
| 07/12/2007 | WO2007078335A2 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| 07/12/2007 | WO2007078110A1 Pharmaceutical formulation containing amlodipine and aspirin |
| 07/12/2007 | WO2007077990A1 Drug delivery material |
| 07/12/2007 | WO2007077961A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 07/12/2007 | WO2007077934A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 07/12/2007 | WO2007077929A1 Therapeutic agent for metabolic syndrome and food containing the therapeutic agent |
| 07/12/2007 | WO2007077861A1 NF-κB INHIBITOR |
| 07/12/2007 | WO2007077457A2 Treatment of equine laminitis with 5-ht1b/ 1d antagonists |
| 07/12/2007 | WO2007077327A1 Association of a sinus current inhibitor if and a conversion enzyme inhibitor |
| 07/12/2007 | WO2007077122A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 07/12/2007 | WO2007076701A1 Extended release of neuregulin for improved cardiac function |
| 07/12/2007 | WO2007052301A3 Process for the preparation of irbesartan |
| 07/12/2007 | WO2007052300A3 Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate |
| 07/12/2007 | WO2007031329A3 Use of a collagen of xenogeneic origin |
| 07/12/2007 | WO2007027780A3 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 07/12/2007 | WO2007017240A3 Composition of n-3 fatty acids having high concentration of epa and/or dha and containing n-6 fatty acids |
| 07/12/2007 | WO2007014033A3 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure |
| 07/12/2007 | WO2006050170A3 Medical devices containing rapamycin analogs |
| 07/12/2007 | WO2003077723A3 Methods and devices for detection and therapy of atheromatous plaque |
| 07/12/2007 | US20070161707 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161706 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161702 Abca1 stabilizer |
| 07/12/2007 | US20070161692 Conformationally restricted polyamine analogs as disease therapies |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161621 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/12/2007 | US20070161620 Isoquinoline compound and pharmaceutical use thereof |